Inventor · disambiguated record
Henry Efrem Pelish
Also filed as: PELISH HENRY E · PELISH HENRY EFREM
12 granted patents·11 pending applications·18 citations·filing 2001–2025
85Inventor score
Top patents by PatentIndex Score
23 records- 0194US11542278B1Heteroaromatic macrocyclic ether chemotherapeutic agentsNUVALENT INC·Filed 2021·Granted Jan 3, 2023·4 cites·30 claims
- 0293US11667649B2Heteroaromatic macrocyclic ether chemotherapeutic agentsNUVALENT INC·Filed 2021·Granted Jun 6, 2023·3 cites·31 claims
- 0386US12037346B2Amino-substituted heteroaryls for treating cancers with EGFR mutationsNUVALENT INC·Filed 2022·Granted Jul 16, 2024·1 cites·43 claims
- 0478US2024352037A1Heteroaromatic macrocyclic ether chemotherapeutic agentsNUVALENT INC·Filed 2024·Application pending·0 cites
- 0574US12054498B2Heteroaromatic macrocyclic ether chemotherapeutic agentsNUVALENT INC·Filed 2022·Granted Aug 6, 2024·0 cites·48 claims
- 0674US6797819B1AlkaloidsHARVARD COLLEGE·Filed 2001·Granted Sep 28, 2004·9 cites·22 claims
- 0773US12275742B2Heteroaromatic macrocyclic ether chemotherapeutic agentsNUVALENT INC·Filed 2022·Granted Apr 15, 2025·0 cites·31 claims
- 0873US9994582B2Cortistatin analogues and syntheses and uses thereofHARVARD COLLEGE·Filed 2016·Granted Jun 12, 2018·1 cites·3 claims
- 0972US2024327435A1Amino-substituted heterocycles for treating cancers with egfr mutationsNUVALENT INC·Filed 2024·Application pending·0 cites
- 1068US2025382304A1Heteroaromatic macrocyclic ether chemotherapeutic agentsNUVALENT INC·Filed 2025·Application pending·0 cites
- 1163US10508121B2Cortistatin analogues and syntheses and uses thereofHARVARD COLLEGE·Filed 2019·Granted Dec 17, 2019·0 cites·12 claims
- 1263US2025326769A1Heteroaromatic macrocyclic ether chemotherapeutic agentsNUVALENT INC·Filed 2023·Application pending·0 cites
- 1360US2025339412A1Methods of treating solid tumor using (19r)-5-chloro-3-ethyl-16-fluoro-10,19-dimethyl-20-oxa-3,4,10,11,23-pentaazapentacyclo[19.3.1.02,6.08,12.013,18]pentacosa-1(24),2(6),4,8,11,13,15,17,21(25),22-decaen-22-amineNUVALENT INC·Filed 2023·Application pending·0 cites
- 1459US10273241B2Cortistatin analogues and syntheses and uses thereofHARVARD COLLEGE·Filed 2018·Granted Apr 30, 2019·0 cites·4 claims
- 1554US2024398768A1Methods of treating solid tumor using heteroaromatic macrocyclic ether compoundsNUVALENT INC·Filed 2022·Application pending·0 cites
- 1647US10273264B2Cortistatin analogues and syntheses and uses thereofHARVARD COLLEGE·Filed 2017·Granted Apr 30, 2019·0 cites·17 claims
- 1746US2018369230A1Targeted selection of patients for treatment with specific cortistatin derivativesHARVARD COLLEGE·Filed 2018·Application pending·0 cites
- 1846US2018135134A1Targeted selection of patients for treatment with cortistatin derivativesHARVARD COLLEGE·Filed 2017·Application pending·0 cites
- 1944US2019062340A1Cortistatin analogsHARVARD COLLEGE·Filed 2016·Application pending·0 cites
- 2043US2018298024A1Cortistatin analogs and uses thereofHARVARD COLLEGE·Filed 2018·Application pending·0 cites
- 2141US10273240B2Cortistatin analogues, syntheses, and uses thereofHARVARD COLLEGE·Filed 2017·Granted Apr 30, 2019·0 cites·23 claims
- 2237US2001024798A1Biomimetic combinatorial synthesisFiled 2001·Application pending·0 cites
- 2326US9193989B2PRPK-TPRKB modulators and uses thereofPARK EUN SUN·Filed 2011·Granted Nov 24, 2015·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Henry Efrem Pelish files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →